# Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers

> **NCT03794843** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shenyang Dongxing Pharmaceutical Technology Co., Ltd.** · enrollment: 26 (estimated)

## Conditions studied

- Bioavailability
- Safety Issues
- Ischemic Cerebrovascular Disease

## Interventions

- **DRUG:** Nimodipine Injection
- **DRUG:** Nimodipine Injection (II)

## Key facts

- **NCT ID:** NCT03794843
- **Lead sponsor:** Shenyang Dongxing Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-23
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2019-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03794843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03794843, "Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03794843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*